FBLG - CIK 0001958777
The table below shows FibroBiologics, Inc.'s income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of revenue | - | - | - | - |
| Gross profit | - | - | - | - |
| R&D | $7.41M | $4.50M | $2.37M | $1.15M |
| SG&A | $9.24M | $9.23M | $6.52M | $3.32M |
| Operating income | -$16.65M | -$13.74M | -$8.89M | -$4.47M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Income tax |
| $0.00 |
| $0.00 |
| $0.00 |
| $0.00 |
| Net income | -$18.65M | -$11.16M | -$16.48M | -$5.12M |
| EPS (diluted) | -$0.42 | -$0.34 | -$0.68 | -$0.18 |